Skip to search.
 TSX Down 0.40% TSX Ventures Up 0.34%

Transition Therapeutics Inc. (TTHI)

-NasdaqGM
6.87 Mar 26, 3:59PM EDT
Add to Portfolio
Prev Close:6.87
Open:N/A
Bid:N/A
Ask:N/A
1y Target Est:11.17
Beta:0.65
Next Earnings Date:N/A
Day's Range:N/A - N/A
52wk Range:4.36 - 8.22
Volume:0
Avg Vol (3m):15,216
Market Cap:242.07M
P/E (ttm):N/A
EPS (ttm):-1.20
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Headlines

Comparison

Symbol% ChgMkt Cap
TTHI 0.00%242.07M
GSK112.24B
MRK163.48B
PFE209.36B

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):N/A
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Jun-15) :-1.31
Quarterly EPS Est (Dec-14) :N/A
Mean Recommendation*:1.0
PEG Ratio (5 yr expected):N/A

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Transition Therapeutics Inc., a biopharmaceutical company, researches and develops therapeutic agents for disease indications in Canada. The company's lead central nervous system drug candidate is ELND005, a Phase II clinical trial product us... View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback